Coherus Oncology, Inc. (CHRS)

1.16 0.00 (0.00%) USD  |  NASDAQ  |  Oct 02, 16:00
1.16 0.00 (0.00%) After-Hours: 20:00
More

Coherus Oncology EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for CHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2021. Start Trial.
Date Value
January 27, 2022 --
November 17, 2021 --
Date Value
October 12, 2021 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --
Savara, Inc. --
Vericel Corp. --